Ozempic and other GLP-1 RAs could slow progression of some cancers, data suggest

🌐 Medical Xpress —
Ozempic and other GLP-1 RAs could slow progression of some cancers, data suggest

AI Summary

Recent data suggests that Ozempic and other GLP-1 receptor agonists may have the potential to slow the progression of certain cancers. These findings represent a significant development in cancer treatment options.

Health Ozempic GLP-1 cancer treatment medical research

Read original source →